YCBD · Healthcare · $5M
After-hours $0.45-3.62%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“매출은 560만 달러로 1년 전보다 20% 늘어, 최근 5백만 달러 안팎에서 6백만 달러대로 올라선 흐름이 확인됐어요.”
In the company's words · 2026 3분기 earnings call